Toker cells of the breast. Morphological and immunohistochemical characterization of 40 cases

被引:30
作者
Di Tommaso, Luca [1 ,2 ]
Franchi, Giada [1 ,2 ]
Destro, Annarita [1 ,2 ]
Broglia, Fabiana [1 ,2 ]
Minuti, Francesco [3 ]
Rahal, Daoud [1 ,2 ]
Roncalli, Massimo [1 ,2 ]
机构
[1] Ist Clin Humanitas, Unita Operat Anat Patol, IRCCS, I-20089 Milan, Italy
[2] Univ Milan, Sch Med, Dept Pathol, Milan, Italy
[3] IRCCS, Clin Trials Off, Humanitas Clin Inst, I-20089 Milan, Italy
关键词
Toker cells; Paget's disease; differential diagnosis; HER2/NTEU; p53/CD138;
D O I
10.1016/j.humpath.2008.01.018
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Toker cells are epithelial cells with clear cytoplasm usually free of cytologic atypia localized within the nipple epidermis. Rarely, they can be so numerous and atypical as to require a careful distinction from malignant cells of Paget's disease. The purpose of this paper was to better define the prevalence of these atypical Toker cells and to investigate phenotypic markets that can be helpful in the differential diagnosis with Paget's disease. Forty cases containing Toker cells were identified in the nipples of 390 patients (10.2%) who underwent complex breast mastectomy. In 24 cases (60%), Toker cells were cytologically bland and benign, disappearing after a few consecutive sections ("normal Toker cells"). In 11 cases (27.5%), Toker cells were more numerous and persistent on serial sections, still retaining bland cytologic features ("hyperplastic Toker cells"). In 5 cases (12.5%), hyperplastic Toker cells also became cytologically atypical ("hyperplastic and atypical Toker cells"). on immunohistochemistry, Toker cells were positive for estrogen (25/25) and progesterone (20/23) receptors, and negative for CD138 (18/19) and p53 (14/14); some hyperplastic and atypical Toker cells (4 cases) and hyperplastic Toker cells (1 case) showed faint immunoreactivity for HER2/NEU. For comparison, Paget's disease were negative for estrogen (6/10) and progesterone (7/10) receptors, and positive for CD138 (7/10), p53 (6/10), and HER2/NEU (9/10). Both Toker cells and Paget's disease stained positive for cytokeratin 7 and epithelia] membrane antigen, and negative for p63. In Conclusion, Toker cells are detectable in 10% of the nipples and are usually cytologically bland, but in 10% of the cases they can be morphologically atypical. The combined use of CD138/p53 is very helpful in distinguishing these atypical Toker cells from those of Paget's disease. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1295 / 1300
页数:6
相关论文
共 15 条
[1]   Immunolabeling pattern of syndecan-1 expression may distinguish pagetoid Bowen's disease, extramammary Paget's disease, and pagetoid malignant melanoma in situ [J].
Bayer-Garner, IB ;
Reed, JA .
JOURNAL OF CUTANEOUS PATHOLOGY, 2004, 31 (02) :169-173
[2]   Paget's disease versus Toker cell hyperplasia in a supernumerary nipple [J].
Decaussin, M ;
Laville, M ;
Mathevet, P ;
Frappart, L .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1998, 432 (03) :289-291
[3]   C-ERBB-2 ONCOPROTEIN EXPRESSION IN MAMMARY AND EXTRAMAMMARY PAGETS-DISEASE - AN IMMUNOHISTOCHEMICAL STUDY [J].
KEATINGS, L ;
SINCLAIR, J ;
WRIGHT, C ;
CORBETT, IP ;
WATCHORN, C ;
HENNESSY, C ;
ANGUS, B ;
LENNARD, T ;
HORNE, CHW .
HISTOPATHOLOGY, 1990, 17 (03) :243-247
[4]   Intraepidermal cytokeratin 7 expression is not restricted to Paget cells but is also seen in Toker cells and Merkel cells [J].
Lundquist, K ;
Kohler, S ;
Rouse, RV .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (02) :212-219
[5]   Toker cells are probably precursors of Paget cell carcinoma: a morphological and ultrastructural description [J].
Marucci, G ;
Betts, CM ;
Golouh, R ;
Peterse, JL ;
Foschini, MP ;
Eusebi, V .
VIRCHOWS ARCHIV, 2002, 441 (02) :117-123
[6]   Intraepidermal cells of Paget's carcinoma of the breast can be genetically different from those of the underlying carcinoma [J].
Morandi, L ;
Pession, A ;
Marucci, GL ;
Foschini, MP ;
Pruneri, G ;
Viale, G ;
Eusebi, V .
HUMAN PATHOLOGY, 2003, 34 (12) :1321-1330
[7]   Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker [J].
Reis, JS ;
Schmitt, FC .
ADVANCES IN ANATOMIC PATHOLOGY, 2002, 9 (05) :280-283
[8]   The role of heregulin-α as a motility factor and amphiregulin as a growth factor in wound healing [J].
Schelfhout, VRJ ;
Coene, ED ;
Delaey, B ;
Waeytens, AAT ;
De Rycke, L ;
Deleu, M ;
De Potter, CR .
JOURNAL OF PATHOLOGY, 2002, 198 (04) :523-533
[9]   Pathogenesis of Paget's disease:: Epidermal heregulin-α, motility factor, and the HER receptor family [J].
Schelfhout, VRJ ;
Coene, ED ;
Delaey, B ;
Thys, S ;
Page, DL ;
De Potter, CR .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (08) :622-628
[10]  
TOKER C, 1970, CANCER, V25, P601, DOI 10.1002/1097-0142(197003)25:3<601::AID-CNCR2820250315>3.0.CO